消化道出血(gastrointestinal bleeding, GIB) 是临床常见的急症之一, 通常可由长期使用抗
血小板药物导致. 随着心血管疾病(cardiovascular diseases, CVD) 患病率的增加 …

New clinical paradigms for treating and preventing antiplate... : Current Opinion in
Gastroenterology New clinical paradigms for treating and preventing antiplatelet …

抗血小板药物治疗是进行心脑血管疾患预防及治疗的基石, 广泛应用于临床.
但长期使用可造成胃肠道损害, 导致消化道出血等严重不良事件发生. 如何在抗血小板治疗的 …

Nowadays, many patients receive chronic antithrombotic therapy for various cardiac
diseases. Antiplatelet drugs are widely used in patients with coronary artery disease. Dual …

Adjusting antiplatelet strategies after antiplatelet-associated gastrointestinal bleeding (GIB)
is a complex clinical challenge. To assess the risk of outcomes at different times of …

Background Use of antiplatelet agents (APAs) have been shown to increase the risk of
gastrointestinal (GI) bleeding despite their cardiovascular benefits. Aim To understand the …

OBJECTIVE Dual antiplatelet therapy (DAPT) is associated with an increased risk of
gastrointestinal (GI) bleeding and is thought to cause upper gastrointestinal bleeding …

Objectives The benefits of dual antiplatelet therapy are counterbalanced by the increased
incidence of gastrointestinal (GI) complications. The aim of this study was to determine the …